Mayo Clinic Laboratories and American Hospital Dubai announce a strategic partnership aimed at improving advanced laboratory diagnostics in the Dubai region. Under the agreement, the two organizations will begin delivering laboratory testing through a collaboration based out of American Hospital Dubai in early 2021.
A small but in-depth study conducted a postmortem evaluation of the heart tissue of 15 patients with COVID-19, including the first postmortem cardiac findings of three patients who had cleared the virus.
The results are part of a comprehensive study of 16,175 cases performed at Mayo Clinic over an 11-year period.
Mayo Clinic's Department of Laboratory Medicine and Pathology has initiated an enterprise-wide digital pathology implementation of the Sectra digital slide review and image storage and management system.
As we enter a second week of protest and unrest throughout the nation sparked by the deaths of George Floyd and Ahmaud Arbery, we want to recognize the heartache and pain felt because of these events. Added to the uncertainty with navigating COVID-19, these troubling incidents have understandably invoked feelings of anger, frustration, sadness, and fear.
We want to express our gratitude for what laboratory professionals do each and every day. As we celebrate Lab Week this year, we recognize more than ever that the laboratory is the backbone of the hospital. Together we will continue to make meeting the needs of our patients the top priority.
PGDx and Mayo Clinic have entered into a collaboration to develop clinic diagnostic solutions for oncology
NanoString Technologies and Mayo Clinic Laboratories have announced a collaboration to develop clinical tests.
"This study offers hope to patients, since each attack in NMO can cause loss of visual or motor function," says Sean Pittock, M.D., a Mayo Clinic neurologist and first author.
Breath Diagnostics, Inc. and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases. The two organizations will initially focus on a test that can detect lung cancer.
Advanced Biological Laboratories (ABL), S.A., a Luxembourg-based diagnostics company and leader in virology genotyping, and Mayo Clinic Laboratories have announced a collaboration. The two organizations are working together to develop a clinical test that will detect mutations associated with antiviral resistance in human cytomegalovirus.
numares and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that will measure clusters of risk factors as opposed to individual biomarkers. The unique testing will use nuclear magnetic resonance technology, focusing on cardiovascular disease, kidney disease and liver cancer—among a few other specific diseases.
Due to the Christmas holiday (recognized on Tuesday, Dec. 25) and the New Year's holiday (recognized on Tuesday, Jan. 1), Mayo Clinic Laboratories’ specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead and note that no pickups or deliveries will be made on Dec. 25 or Jan. 1 by Mayo couriers, FedEx, or UPS.